Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T van Oosterom

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Seminars in Oncology|December 1, 1995
Docetaxel (Taxotere): an effective agent in the management of second-line breast cancerA T van Oosterom
Seminars in Oncology|August 7, 1999
Docetaxel (Taxotere) and gemcitabine phase I and early phase II studies: results to date and an overview of ongoing studiesA T van Oosterom
Hematology/Oncology Clinics of North America|August 1, 1995
New drugs for the treatment of sarcomasA T van Oosterom, J Verweij
Journal Belge De Radiologie|August 1, 1992
The multidisciplinary approach to treatment of soft tissue sarcomasJ Verweij, A T van Oosterom
Anti-Cancer Drugs|January 12, 2000
Irinotecan in cancers of the lung and cervixA Sandler, A T van Oosterom
Forum (Genoa, Italy)|September 30, 1999
Neoadjuvant/primary chemotherapy in cancer treatment: what advantage?W Wynendaele, A T van Oosterom
Journal Belge De Radiologie|March 1, 1993
Radiotherapy and chemotherapy in testis tumorsP Scalliet, A T Van Oosterom
Seminars in Oncology|February 1, 1989
The role of ifosfamide in the treatment of sarcomasL Y Dirix, A T Van Oosterom
Current Opinion in Oncology|August 1, 1991
Chondrosarcoma and other rare bone sarcomasL Y Dirix, A T Van Oosterom
Cancer Treatment Reports|April 1, 1983
CAP (cyclophosphamide, doxorubicin, and cisplatin) regimen in adrenal cortical carcinomaH van Slooten, A T van Oosterom
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Seminars in Oncology|December 1, 1995
Docetaxel (Taxotere): an effective agent in the management of second-line breast cancerA T van Oosterom
Seminars in Oncology|August 7, 1999
Docetaxel (Taxotere) and gemcitabine phase I and early phase II studies: results to date and an overview of ongoing studiesA T van Oosterom
Hematology/Oncology Clinics of North America|August 1, 1995
New drugs for the treatment of sarcomasA T van Oosterom, J Verweij
Journal Belge De Radiologie|August 1, 1992
The multidisciplinary approach to treatment of soft tissue sarcomasJ Verweij, A T van Oosterom
Anti-Cancer Drugs|January 12, 2000
Irinotecan in cancers of the lung and cervixA Sandler, A T van Oosterom
Forum (Genoa, Italy)|September 30, 1999
Neoadjuvant/primary chemotherapy in cancer treatment: what advantage?W Wynendaele, A T van Oosterom
Journal Belge De Radiologie|March 1, 1993
Radiotherapy and chemotherapy in testis tumorsP Scalliet, A T Van Oosterom
Seminars in Oncology|February 1, 1989
The role of ifosfamide in the treatment of sarcomasL Y Dirix, A T Van Oosterom
Current Opinion in Oncology|August 1, 1991
Chondrosarcoma and other rare bone sarcomasL Y Dirix, A T Van Oosterom
Cancer Treatment Reports|April 1, 1983
CAP (cyclophosphamide, doxorubicin, and cisplatin) regimen in adrenal cortical carcinomaH van Slooten, A T van Oosterom
Pageof 20